EP1208212A4 - Fibrin sealant as a transfection/transformation vehicle for gene therapy - Google Patents

Fibrin sealant as a transfection/transformation vehicle for gene therapy

Info

Publication number
EP1208212A4
EP1208212A4 EP99935322A EP99935322A EP1208212A4 EP 1208212 A4 EP1208212 A4 EP 1208212A4 EP 99935322 A EP99935322 A EP 99935322A EP 99935322 A EP99935322 A EP 99935322A EP 1208212 A4 EP1208212 A4 EP 1208212A4
Authority
EP
European Patent Office
Prior art keywords
transfection
gene therapy
fibrin sealant
transformation vehicle
transformation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99935322A
Other languages
German (de)
French (fr)
Other versions
EP1208212A1 (en
Inventor
Stewart A Cederholm-Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VIVOLUTION AS
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of EP1208212A1 publication Critical patent/EP1208212A1/en
Publication of EP1208212A4 publication Critical patent/EP1208212A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP99935322A 1999-06-16 1999-06-16 Fibrin sealant as a transfection/transformation vehicle for gene therapy Withdrawn EP1208212A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/013508 WO2000077227A1 (en) 1999-06-16 1999-06-16 Fibrin sealant as a transfection/transformation vehicle for gene therapy

Publications (2)

Publication Number Publication Date
EP1208212A1 EP1208212A1 (en) 2002-05-29
EP1208212A4 true EP1208212A4 (en) 2007-05-02

Family

ID=22272977

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99935322A Withdrawn EP1208212A4 (en) 1999-06-16 1999-06-16 Fibrin sealant as a transfection/transformation vehicle for gene therapy

Country Status (4)

Country Link
EP (1) EP1208212A4 (en)
JP (1) JP2003502047A (en)
CA (1) CA2375346A1 (en)
WO (1) WO2000077227A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0423681D0 (en) * 2004-10-26 2004-11-24 Sec Dep For Environment Food & Vaccine and nucleic acids
AU2009268052B2 (en) 2008-07-09 2015-05-28 Mallinckrodt Pharma Ip Trading D.A.C. Recombinant fibrinogen

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024929A2 (en) * 1994-03-15 1995-09-21 Brown University Research Foundation Polymeric gene delivery system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626863A (en) * 1992-02-28 1997-05-06 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
CN1091315A (en) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 Fibrin sealant compositions and methods of use thereof
US5833651A (en) * 1996-11-08 1998-11-10 Medtronic, Inc. Therapeutic intraluminal stents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024929A2 (en) * 1994-03-15 1995-09-21 Brown University Research Foundation Polymeric gene delivery system

Also Published As

Publication number Publication date
CA2375346A1 (en) 2000-12-21
WO2000077227A1 (en) 2000-12-21
EP1208212A1 (en) 2002-05-29
JP2003502047A (en) 2003-01-21

Similar Documents

Publication Publication Date Title
IL143401A0 (en) Self-propelled drive wheel
AU7578600A (en) Multi-dose syringe driver
AU2002348163A1 (en) Therapeutic methods for nucleic acid delivery vehicles
AUPP805599A0 (en) A direct smelting process
AU4595300A (en) Reactions using lewis acids
AUPQ008799A0 (en) Genome sequencing
AU1335201A (en) Hydrodesulfurization process
AU6288599A (en) Fibrin sealant applicator system
IL143400A0 (en) Self-propelled drive wheel
AU3583000A (en) Method for direct steelmaking
AU4708501A (en) Hybrid digital-analog controller
AU2732000A (en) Reverse gene therapy
EP1144631A3 (en) Insulin-synthesis genes
AU1151501A (en) Stud for tire
AU5088600A (en) Gene therapy products
IL143398A0 (en) Self-propelled drive wheel
GB0025890D0 (en) Gene therapy
AU1284500A (en) A driver primarily for posts
GB9900009D0 (en) Gene therapy
AU6843400A (en) Jack for vehicles
AU6871900A (en) Tsg-like gene
AU4144600A (en) Cyp2a6 gene judgment methods
GB0406539D0 (en) Gene therapy
AU4552700A (en) Gene therapy
AUPQ087199A0 (en) Tyre

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020109

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20070314

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 48/00 20060101AFI20070308BHEP

17Q First examination report despatched

Effective date: 20070716

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: VIVOLUTION A/S

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20080327